Vivoryon Therapeutics AG's total assets for Q4 2024 were €11.28M, a decrease of -33.59% from the previous quarter. GB:0R3M total liabilities were €3.40M for the fiscal quarter, a 13.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.